Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-04-18

AUTHORS

S.-H. Choi, T. Kim, K.-H. Park, Y. G. Kwak, J.-W. Chung, M. S. Lee

ABSTRACT

The administration of neuraminidase inhibitors (NAIs) within 2 days after the onset of symptoms (early NAI therapy) has been shown to reduce mortality in adult patients with severe influenza. However, there is no sufficiently solid evidence supporting the effectiveness of early NAI therapy on mortality. We reviewed the clinical data from 506 adult patients who were hospitalized for influenza between March 2010 and March 2014, to investigate the impact of early NAI therapy on mortality. Nearly one-third of the study patients were infected with influenza B (influenza A, influenza B, and co-infection of both in 68.8%, 28.1%, and 3.2%, respectively), and were diagnosed using the polymerase chain reaction (PCR) method (33.6%). Less than half (233, 46.0%) had received early NAI therapy. Patients with early NAI therapy were admitted to the hospital earlier, more frequently infected with influenza A, and more frequently diagnosed using rapid influenza detection tests compared to those without early NAI therapy. Although patients without early NAI therapy presented with more serious clinical manifestations, such as an initial symptom of dyspnea, pneumonia, and intensive care unit admission, than those with early NAI therapy, the in-hospital mortality of the former (2.9%, 8/273) did not differ from that of the latter (3.4%, 8/233) (p = 0.75). We did not find a reduction in mortality associated with early NAI therapy in adult patients hospitalized for influenza. Further clinical studies including a large number of influenza B-infected patients with virus identification using PCR methodology rather than viral culture may be required to confirm the beneficial impact of early NAI therapy on mortality. More... »

PAGES

1673-1677

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-017-2982-z

DOI

http://dx.doi.org/10.1007/s10096-017-2982-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084864733

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28417272


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospital Mortality", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza A virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenzavirus B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuraminidase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Public Health Surveillance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411651.6", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Choi", 
        "givenName": "S.-H.", 
        "id": "sg:person.01042104746.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042104746.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412678.e", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "T.", 
        "id": "sg:person.013713642540.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013713642540.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.289247.2", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "K.-H.", 
        "id": "sg:person.01233401052.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401052.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411633.2", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwak", 
        "givenName": "Y. G.", 
        "id": "sg:person.0601755057.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601755057.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411651.6", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "J.-W.", 
        "id": "sg:person.01201031350.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201031350.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.289247.2", 
          "name": [
            "Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "M. S.", 
        "id": "sg:person.01047705072.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047705072.05"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-04-18", 
    "datePublishedReg": "2017-04-18", 
    "description": "The administration of neuraminidase inhibitors (NAIs) within 2\u00a0days after the onset of symptoms (early NAI therapy) has been shown to reduce mortality in adult patients with severe influenza. However, there is no sufficiently solid evidence supporting the effectiveness of early NAI therapy on mortality. We reviewed the clinical data from 506 adult patients who were hospitalized for influenza between March 2010 and March 2014, to investigate the impact of early NAI therapy on mortality. Nearly one-third of the study patients were infected with influenza B (influenza A, influenza B, and co-infection of both in 68.8%, 28.1%, and 3.2%, respectively), and were diagnosed using the polymerase chain reaction (PCR) method (33.6%). Less than half (233, 46.0%) had received early NAI therapy. Patients with early NAI therapy were admitted to the hospital earlier, more frequently infected with influenza A, and more frequently diagnosed using rapid influenza detection tests compared to those without early NAI therapy. Although patients without early NAI therapy presented with more serious clinical manifestations, such as an initial symptom of dyspnea, pneumonia, and intensive care unit admission, than those with early NAI therapy, the in-hospital mortality of the former (2.9%, 8/273) did not differ from that of the latter (3.4%, 8/233) (p\u00a0=\u00a00.75). We did not find a reduction in mortality associated with early NAI therapy in adult patients hospitalized for influenza. Further clinical studies including a large number of influenza B-infected patients with virus identification using PCR methodology rather than viral culture may be required to confirm the beneficial impact of early NAI therapy on mortality.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10096-017-2982-z", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "early NAI therapy", 
      "NAI therapy", 
      "adult patients", 
      "neuraminidase inhibitors", 
      "influenza B", 
      "rapid influenza detection test", 
      "intensive care unit admission", 
      "care unit admission", 
      "retrospective cohort study", 
      "onset of symptoms", 
      "further clinical studies", 
      "serious clinical manifestations", 
      "severe influenza", 
      "unit admission", 
      "hospital mortality", 
      "study patients", 
      "cohort study", 
      "early administration", 
      "polymerase chain reaction method", 
      "clinical manifestations", 
      "viral culture", 
      "influenza A", 
      "initial symptoms", 
      "clinical data", 
      "clinical studies", 
      "chain reaction method", 
      "patients", 
      "therapy", 
      "mortality", 
      "influenza", 
      "symptoms", 
      "one-third", 
      "administration", 
      "virus identification", 
      "PCR methodology", 
      "detection test", 
      "beneficial impact", 
      "solid evidence", 
      "inhibitors", 
      "dyspnea", 
      "pneumonia", 
      "admission", 
      "hospital", 
      "survival", 
      "manifestations", 
      "onset", 
      "study", 
      "days", 
      "evidence", 
      "half", 
      "impact", 
      "test", 
      "reduction", 
      "large number", 
      "culture", 
      "identification", 
      "data", 
      "number", 
      "effectiveness", 
      "method", 
      "reaction method", 
      "methodology"
    ], 
    "name": "Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study", 
    "pagination": "1673-1677", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084864733"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-017-2982-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28417272"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-017-2982-z", 
      "https://app.dimensions.ai/details/publication/pub.1084864733"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_733.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10096-017-2982-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-017-2982-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-017-2982-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-017-2982-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-017-2982-z'


 

This table displays all metadata directly associated to this object as RDF triples.

243 TRIPLES      20 PREDICATES      106 URIs      98 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-017-2982-z schema:about N05392a08093e4216b0c4e999b47ccbcd
2 N10ae2b03a0284940816cebd622743303
3 N44a9f6d2c87641e6a54d1ce526eb0406
4 N48e522550c7a42a9b90797835ee03e14
5 N4f8fdb849af94b7e8949b5775f6d497a
6 N5036be307e934fb7ab7219fca7270f89
7 N5e0982f12ca644ba961e1eda2370719a
8 N727e55cc07274ad197106aae40fdbbe6
9 Na37b6ed4975741598a79c111fc87b507
10 Na464a15bce9d42449af694dd3094305d
11 Nabc42db58ac24781808c932c5da5483b
12 Nad7512504dab4537a0bd085de01bc574
13 Nb7ab504ef57547bb8375e2efc0eb98b6
14 Ndadd500cd9dc461eb911b7e1dcf3ca0c
15 Ndbec17937fa14e19969dbce7b3194c74
16 Nde5d0d27e43e444c93c28dbae314d078
17 Neb9f689182ba4a7ba577445f34aae516
18 Nf49b749b3c544fbebf6667805abee63d
19 Nfc1bf1bd2535446789b5dda79c186161
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N98b95d6d4df349c2bd43513af41ce4f3
23 schema:datePublished 2017-04-18
24 schema:datePublishedReg 2017-04-18
25 schema:description The administration of neuraminidase inhibitors (NAIs) within 2 days after the onset of symptoms (early NAI therapy) has been shown to reduce mortality in adult patients with severe influenza. However, there is no sufficiently solid evidence supporting the effectiveness of early NAI therapy on mortality. We reviewed the clinical data from 506 adult patients who were hospitalized for influenza between March 2010 and March 2014, to investigate the impact of early NAI therapy on mortality. Nearly one-third of the study patients were infected with influenza B (influenza A, influenza B, and co-infection of both in 68.8%, 28.1%, and 3.2%, respectively), and were diagnosed using the polymerase chain reaction (PCR) method (33.6%). Less than half (233, 46.0%) had received early NAI therapy. Patients with early NAI therapy were admitted to the hospital earlier, more frequently infected with influenza A, and more frequently diagnosed using rapid influenza detection tests compared to those without early NAI therapy. Although patients without early NAI therapy presented with more serious clinical manifestations, such as an initial symptom of dyspnea, pneumonia, and intensive care unit admission, than those with early NAI therapy, the in-hospital mortality of the former (2.9%, 8/273) did not differ from that of the latter (3.4%, 8/233) (p = 0.75). We did not find a reduction in mortality associated with early NAI therapy in adult patients hospitalized for influenza. Further clinical studies including a large number of influenza B-infected patients with virus identification using PCR methodology rather than viral culture may be required to confirm the beneficial impact of early NAI therapy on mortality.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N20f7f29a61eb49db81c23930a6b66c4d
29 N8fee3101f9904abdbe9e5c9552955a16
30 sg:journal.1093599
31 schema:keywords NAI therapy
32 PCR methodology
33 administration
34 admission
35 adult patients
36 beneficial impact
37 care unit admission
38 chain reaction method
39 clinical data
40 clinical manifestations
41 clinical studies
42 cohort study
43 culture
44 data
45 days
46 detection test
47 dyspnea
48 early NAI therapy
49 early administration
50 effectiveness
51 evidence
52 further clinical studies
53 half
54 hospital
55 hospital mortality
56 identification
57 impact
58 influenza
59 influenza A
60 influenza B
61 inhibitors
62 initial symptoms
63 intensive care unit admission
64 large number
65 manifestations
66 method
67 methodology
68 mortality
69 neuraminidase inhibitors
70 number
71 one-third
72 onset
73 onset of symptoms
74 patients
75 pneumonia
76 polymerase chain reaction method
77 rapid influenza detection test
78 reaction method
79 reduction
80 retrospective cohort study
81 serious clinical manifestations
82 severe influenza
83 solid evidence
84 study
85 study patients
86 survival
87 symptoms
88 test
89 therapy
90 unit admission
91 viral culture
92 virus identification
93 schema:name Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study
94 schema:pagination 1673-1677
95 schema:productId N7e04773ac4cc4d128e2b1f260d56e8cc
96 Nd182402e839a474bba0b82074845098d
97 Nec15be117d044f1ca22db17d1a3266ed
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084864733
99 https://doi.org/10.1007/s10096-017-2982-z
100 schema:sdDatePublished 2022-12-01T06:36
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N5c81ec1d6009418ebe73325bd41a4486
103 schema:url https://doi.org/10.1007/s10096-017-2982-z
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N05392a08093e4216b0c4e999b47ccbcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Influenza, Human
109 rdf:type schema:DefinedTerm
110 N0e3413e9812049ba88f013cf88b96e50 rdf:first sg:person.0601755057.44
111 rdf:rest Nba1bc6d2f5394a01899b4f39ad9e5e69
112 N10ae2b03a0284940816cebd622743303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Antiviral Agents
114 rdf:type schema:DefinedTerm
115 N20f7f29a61eb49db81c23930a6b66c4d schema:issueNumber 9
116 rdf:type schema:PublicationIssue
117 N39cc11bd99164643a81a7e5fa9d1727d rdf:first sg:person.01233401052.25
118 rdf:rest N0e3413e9812049ba88f013cf88b96e50
119 N44a9f6d2c87641e6a54d1ce526eb0406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adult
121 rdf:type schema:DefinedTerm
122 N48e522550c7a42a9b90797835ee03e14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Male
124 rdf:type schema:DefinedTerm
125 N4f8fdb849af94b7e8949b5775f6d497a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Young Adult
127 rdf:type schema:DefinedTerm
128 N5036be307e934fb7ab7219fca7270f89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Retrospective Studies
130 rdf:type schema:DefinedTerm
131 N5c81ec1d6009418ebe73325bd41a4486 schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N5e0982f12ca644ba961e1eda2370719a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Female
135 rdf:type schema:DefinedTerm
136 N727e55cc07274ad197106aae40fdbbe6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Influenza A virus
138 rdf:type schema:DefinedTerm
139 N74e4add34a2c43c0902722c2f4571f29 rdf:first sg:person.01047705072.05
140 rdf:rest rdf:nil
141 N7e04773ac4cc4d128e2b1f260d56e8cc schema:name pubmed_id
142 schema:value 28417272
143 rdf:type schema:PropertyValue
144 N8fee3101f9904abdbe9e5c9552955a16 schema:volumeNumber 36
145 rdf:type schema:PublicationVolume
146 N98b95d6d4df349c2bd43513af41ce4f3 rdf:first sg:person.01042104746.10
147 rdf:rest Nbde4af7b384149509aa95fff6cf15ab0
148 Na37b6ed4975741598a79c111fc87b507 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged, 80 and over
150 rdf:type schema:DefinedTerm
151 Na464a15bce9d42449af694dd3094305d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Hospital Mortality
153 rdf:type schema:DefinedTerm
154 Nabc42db58ac24781808c932c5da5483b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aged
156 rdf:type schema:DefinedTerm
157 Nad7512504dab4537a0bd085de01bc574 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Hospitalization
159 rdf:type schema:DefinedTerm
160 Nb7ab504ef57547bb8375e2efc0eb98b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Adolescent
162 rdf:type schema:DefinedTerm
163 Nba1bc6d2f5394a01899b4f39ad9e5e69 rdf:first sg:person.01201031350.15
164 rdf:rest N74e4add34a2c43c0902722c2f4571f29
165 Nbde4af7b384149509aa95fff6cf15ab0 rdf:first sg:person.013713642540.39
166 rdf:rest N39cc11bd99164643a81a7e5fa9d1727d
167 Nd182402e839a474bba0b82074845098d schema:name doi
168 schema:value 10.1007/s10096-017-2982-z
169 rdf:type schema:PropertyValue
170 Ndadd500cd9dc461eb911b7e1dcf3ca0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Humans
172 rdf:type schema:DefinedTerm
173 Ndbec17937fa14e19969dbce7b3194c74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Influenzavirus B
175 rdf:type schema:DefinedTerm
176 Nde5d0d27e43e444c93c28dbae314d078 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Treatment Outcome
178 rdf:type schema:DefinedTerm
179 Neb9f689182ba4a7ba577445f34aae516 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Middle Aged
181 rdf:type schema:DefinedTerm
182 Nec15be117d044f1ca22db17d1a3266ed schema:name dimensions_id
183 schema:value pub.1084864733
184 rdf:type schema:PropertyValue
185 Nf49b749b3c544fbebf6667805abee63d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Neuraminidase
187 rdf:type schema:DefinedTerm
188 Nfc1bf1bd2535446789b5dda79c186161 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Public Health Surveillance
190 rdf:type schema:DefinedTerm
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
195 schema:name Clinical Sciences
196 rdf:type schema:DefinedTerm
197 sg:journal.1093599 schema:issn 0934-9723
198 1435-4373
199 schema:name European Journal of Clinical Microbiology & Infectious Diseases
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01042104746.10 schema:affiliation grid-institutes:grid.411651.6
203 schema:familyName Choi
204 schema:givenName S.-H.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042104746.10
206 rdf:type schema:Person
207 sg:person.01047705072.05 schema:affiliation grid-institutes:grid.289247.2
208 schema:familyName Lee
209 schema:givenName M. S.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047705072.05
211 rdf:type schema:Person
212 sg:person.01201031350.15 schema:affiliation grid-institutes:grid.411651.6
213 schema:familyName Chung
214 schema:givenName J.-W.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201031350.15
216 rdf:type schema:Person
217 sg:person.01233401052.25 schema:affiliation grid-institutes:grid.289247.2
218 schema:familyName Park
219 schema:givenName K.-H.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401052.25
221 rdf:type schema:Person
222 sg:person.013713642540.39 schema:affiliation grid-institutes:grid.412678.e
223 schema:familyName Kim
224 schema:givenName T.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013713642540.39
226 rdf:type schema:Person
227 sg:person.0601755057.44 schema:affiliation grid-institutes:grid.411633.2
228 schema:familyName Kwak
229 schema:givenName Y. G.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601755057.44
231 rdf:type schema:Person
232 grid-institutes:grid.289247.2 schema:alternateName Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea
233 schema:name Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea
234 rdf:type schema:Organization
235 grid-institutes:grid.411633.2 schema:alternateName Division of Infectious Diseases, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea
236 schema:name Division of Infectious Diseases, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea
237 rdf:type schema:Organization
238 grid-institutes:grid.411651.6 schema:alternateName Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea
239 schema:name Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea
240 rdf:type schema:Organization
241 grid-institutes:grid.412678.e schema:alternateName Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
242 schema:name Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
243 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...